NDC00182-0813-05 — ORPHENADRINE CITRATE EXTENDED-RE

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC00182-0813-05: ORPHENADRINE CITRATE EXTENDED-RE.

ORPHENADRINE CITRATE EXTENDED-RE. Key specifications include special_features: LONG ACTION METHOD:EXTENDED RELEASE;, primary_container_type: BOTTLE, primary_container_content_quantity: 500.000 TABLETS, active_medicament_medicinal_strength: 100.000 MILLIGRAMS ORPHENADRINE CITRATE ACTIVE INGREDIENT. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-214-1647, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC00182-0813-05

NSN: 6505-01-214-1647
FSC: 6505 — Drugs and Biologicals
CAGE: 63488 — GOLDLINE LABORATORIES, INC. DBA GOLDLINE LABORATORIES (USA)

SPECIFICATIONS

special_features	LONG ACTION METHOD:EXTENDED RELEASE;
primary_container_type	BOTTLE
primary_container_content_quantity	500.000 TABLETS
active_medicament_medicinal_strength	100.000 MILLIGRAMS ORPHENADRINE CITRATE ACTIVE INGREDIENT
NSN	6505-01-214-1647

COMPONENT DIAGRAM

KEY FEATURES

•

PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS

•

PRIMARY CONTAINER TYPE: BOTTLE

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS ORPHENADRINE CITRATE ACTIVE INGREDIENT

TECHNICAL CHARACTERISTICS

PRIMARY CONTAINER CONTENT QUANTITY	500.000 TABLETS
PRIMARY CONTAINER TYPE	BOTTLE
SPECIAL FEATURES	LONG ACTION METHOD:EXTENDED RELEASE;
ACTIVE MEDICAMENT MEDICINAL STRENGTH	100.000 MILLIGRAMS ORPHENADRINE CITRATE ACTIVE INGREDIENT

SUBSTITUTES & CROSS-REFERENCES 2

NORFLEXReference document

Same NSN cross-reference

Reference document — Secondary reference

NDC00089-221-50Reference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedNo demilitarization required

Ready to buy NDC00182-0813-05?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC00182-0813-05?

NDC00182-0813-05 is a ORPHENADRINE CITRATE EXTENDED-RE.

What parts can replace NDC00182-0813-05?

There are 2 known substitutes for NDC00182-0813-05: NORFLEX, NDC00089-221-50. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC00182-0813-05?

NDC00182-0813-05 is cataloged in the U.S. Government catalog under NSN 6505-01-214-1647. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC00182-0813-05 — ORPHENADRINE CITRATE EXTENDED-RE

Request a Quote — NDC00182-0813-05